These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 29929978

  • 1. Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice.
    Spurthi KM, Sarikhani M, Mishra S, Desingu PA, Yadav S, Rao S, Maity S, Tamta AK, Kumar S, Majumdar S, Jain A, Raghuraman A, Khan D, Singh I, Samuel RJ, Ramachandra SG, Nandi D, Sundaresan NR.
    J Biol Chem; 2018 Aug 24; 293(34):13073-13089. PubMed ID: 29929978
    [Abstract] [Full Text] [Related]

  • 2. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1.
    Xia P, Chen J, Liu Y, Fletcher M, Jensen BC, Cheng Z.
    J Biol Chem; 2020 Mar 27; 295(13):4265-4276. PubMed ID: 32075913
    [Abstract] [Full Text] [Related]

  • 3. Forkhead Box O1 Regulates Macrophage Polarization Following Staphylococcus aureus Infection: Experimental Murine Data and Review of the Literature.
    Wang YC, Ma HD, Yin XY, Wang YH, Liu QZ, Yang JB, Shi QH, Sun B, Gershwin ME, Lian ZX.
    Clin Rev Allergy Immunol; 2016 Dec 27; 51(3):353-369. PubMed ID: 26924010
    [Abstract] [Full Text] [Related]

  • 4. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
    Weeks KL, Tham YK, Yildiz SG, Alexander Y, Donner DG, Kiriazis H, Harmawan CA, Hsu A, Bernardo BC, Matsumoto A, DePinho RA, Abel ED, Woodcock EA, McMullen JR.
    Am J Physiol Heart Circ Physiol; 2021 Apr 01; 320(4):H1470-H1485. PubMed ID: 33577435
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptor 2 signaling deficiency in cardiac cells ameliorates Ang II-induced cardiac inflammation and remodeling.
    Ye S, Lin K, Wu G, Xu MJ, Shan P, Huang W, Wang Y, Liang G.
    Transl Res; 2021 Jul 01; 233():62-76. PubMed ID: 33652137
    [Abstract] [Full Text] [Related]

  • 6. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
    Evans-Anderson HJ, Alfieri CM, Yutzey KE.
    Circ Res; 2008 Mar 28; 102(6):686-94. PubMed ID: 18218983
    [Abstract] [Full Text] [Related]

  • 7. Elevated Expression of TLR2 in Aging Hearts Exacerbates Cardiac Inflammatory Response and Adverse Remodeling Following Ischemia and Reperfusion Injury.
    Zhai Y, Ao L, Yao Q, The E, Fullerton DA, Meng X.
    Front Immunol; 2022 Mar 28; 13():891570. PubMed ID: 35493479
    [Abstract] [Full Text] [Related]

  • 8. TLR2 Plays a Critical Role in HMGB1-Induced Glomeruli Cell Proliferation Through the FoxO1 Signaling Pathway in Lupus Nephritis.
    Feng XJ, Wu C, Yan GF, Liu QJ, Liu JX, Hao J, Xing LL, Yang M, Liu SX.
    J Interferon Cytokine Res; 2016 Apr 28; 36(4):258-66. PubMed ID: 26799193
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation.
    Wang L, Li YL, Zhang CC, Cui W, Wang X, Xia Y, Du J, Li HH.
    Cardiovasc Res; 2014 Mar 01; 101(3):383-92. PubMed ID: 24259498
    [Abstract] [Full Text] [Related]

  • 10. Toll-like receptor-2 in cardiomyocytes and macrophages mediates isoproterenol-induced cardiac inflammation and remodeling.
    Qian J, Liang S, Wang Q, Xu J, Huang W, Wu G, Liang G.
    FASEB J; 2023 Feb 01; 37(2):e22740. PubMed ID: 36583707
    [Abstract] [Full Text] [Related]

  • 11. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
    Lei L, Hu H, Lei Y, Feng J.
    Biochem Biophys Res Commun; 2018 Nov 30; 506(3):668-673. PubMed ID: 30454704
    [Abstract] [Full Text] [Related]

  • 12. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
    Kyriazis ID, Hoffman M, Gaignebet L, Lucchese AM, Markopoulou E, Palioura D, Wang C, Bannister TD, Christofidou-Solomidou M, Oka SI, Sadoshima J, Koch WJ, Goldberg IJ, Yang VW, Bialkowska AB, Kararigas G, Drosatos K.
    Circ Res; 2021 Feb 05; 128(3):335-357. PubMed ID: 33539225
    [Abstract] [Full Text] [Related]

  • 13. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
    Wang J, Bai J, Duan P, Wang H, Li Y, Zhu Q.
    J Cell Mol Med; 2021 Apr 05; 25(8):3935-3949. PubMed ID: 33547878
    [Abstract] [Full Text] [Related]

  • 14. TLR2 deficiency attenuates skeletal muscle atrophy in mice.
    Kim DS, Cha HN, Jo HJ, Song IH, Baek SH, Dan JM, Kim YW, Kim JY, Lee IK, Seo JS, Park SY.
    Biochem Biophys Res Commun; 2015 Apr 10; 459(3):534-40. PubMed ID: 25749338
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
    Bagchi AK, Akolkar G, Mandal S, Ayyappan P, Yang X, Singal PK.
    Am J Physiol Heart Circ Physiol; 2017 Jun 01; 312(6):H1238-H1247. PubMed ID: 28432060
    [Abstract] [Full Text] [Related]

  • 16. Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload.
    Wang JW, Fontes MSC, Wang X, Chong SY, Kessler EL, Zhang YN, de Haan JJ, Arslan F, de Jager SCA, Timmers L, van Veen TAB, Lam CSP, Kleijn DPV.
    Sci Rep; 2017 Aug 23; 7(1):9193. PubMed ID: 28835616
    [Abstract] [Full Text] [Related]

  • 17. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism.
    Ha T, Lu C, Liu L, Hua F, Hu Y, Kelley J, Singh K, Kao RL, Kalbfleisch J, Williams DL, Gao X, Li C.
    Am J Physiol Heart Circ Physiol; 2010 Mar 23; 298(3):H984-91. PubMed ID: 20061538
    [Abstract] [Full Text] [Related]

  • 18. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
    Gopal K, Saleme B, Al Batran R, Aburasayn H, Eshreif A, Ho KL, Ma WK, Almutairi M, Eaton F, Gandhi M, Park EA, Sutendra G, Ussher JR.
    Am J Physiol Heart Circ Physiol; 2017 Sep 01; 313(3):H479-H490. PubMed ID: 28687587
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.